Filing Flows

Filing Flows › Lifecore Biomedical (LFCR) › Next earnings date

Lifecore Biomedical (LFCR) earnings: missed the estimate

Lifecore Biomedical (LFCR) reported on Nov 4, 2026 and missed the EPS estimate: −$1.08 against −$0.30 (-263.0%). Revenue was $25.3M for Q1 FY27, -19% year over year. It beat the EPS estimate in 20% of the quarters on record.

Last result−263.0% vs estimate
Beat rate20%

The last report

Lifecore Biomedical reported revenue of $25.3M for the first quarter fiscal 2027 (-19% Y/Y), net loss $40.1M: CDMO $17.8M, HA manufacturing $7.5M. How it makes money → · Every quarter →

Lifecore Biomedical: EPS against the estimate, last 5 reportsLifecore Biomedical: EPS against the estimate, last 5 reportsEstimateReported−$0.15−$0.47Apr 25−$0.16−$0.16Mar 26−$0.29−$0.43May 26−$0.22−$0.19Aug 26−$0.30−$1.08Nov 26
Latest (Nov 26): Estimate −$0.30, Reported −$1.08.

Lifecore Biomedical's latest quarter

Lifecore Biomedical, Q1 FY27: revenue $25.3M (-19% year over year), operating margin -3.5%, net loss $40.1M, operating cash flow $6.9M. The chart follows the revenue to costs, profit and cash.

Questions

Did Lifecore Biomedical beat earnings?

Lifecore Biomedical (LFCR) reported on Nov 4, 2026 and missed the EPS estimate: −$1.08 against −$0.30 (-263.0%).

When does LFCR report earnings?

The next date is not set yet.

Does Lifecore Biomedical usually beat earnings?

It beat the consensus EPS estimate in 20% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.